The expression of CD9 is associated with ESCC staging and lymph node metastasis, and the expression of CD9 in metastatic ESCC tissues is significantly higher than that in non-metastatic tissues, indicating that CD9 is a characteristic of malignant progression (15). The gene discussed is CD9; the disease is metastatic malignant neoplasm in the lymph nodes.